国产亚洲精品久久久久秋,乱中年女人伦,日本成熟视频免费视频,亚洲av日韩精品久久久久久a

OrganRegen-Dexamethasone (DHAP)（C500220）

產(chǎn)品中心 > 類器官小分子 > OrganRegen-Dexamethasone (DHAP)（C500220）

OrganRegen-Dexamethasone (DHAP)（C500220）

Dexamethasone (DHAP)
貨號(hào)：C500220
規(guī)格：10mM (in 1mL DMSO)
品牌：OrganRegen
價(jià)格： ￥500.00
分享到：
10mM

Dexamethasone (DHAP)

貨號(hào)：C500220

規(guī)格：10mM (in 1mL DMSO)

品牌：OrganRegen


產(chǎn)品介紹

DESCRIPTION

Background

Dexamethasone is a glucocorticoid receptor agonist. Dexamethasone also significantly decreases CD11b, CD18, and CD62L expression on neutrophils, and CD11b and CD18 expression on monocytes. Dexamethasone is highly effective in the control of COVID-19 infection. Dexamethasone inhibits production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.

Alias

Synonyms,地塞米松,Hexadecadrol,Prednisolone F

M. W t

392.46

Formula

C22H29FO5

CAS No

50-02-2

Storage

Powder

-20°C

3 years                                                                                                                             

In solvent

-80°C     

2 years                  

Solubility

DMSO 

250 mg/mL(637.01 mM; ultrasonic and warming and heat to 60°C)

Ethanol 

8.33 mg/mL(21.23 mM; Need ultrasonic)


H2O

< 0.1 mg/mL(insoluble)

 

技術(shù)參數(shù)

BIOLOGICAL ALTIVITY

In Vitro   

Dexamethasone regulates several transcription factors, including activator protein-1, nuclear factor-AT, and nuclear factor-kB, leading to the activation and repression of key genes involved in the inflammatory response[1].

Dexamethasone potently inhibits granulocyte-macrophage colony stimulating factor (GM-CSF) release from A549 cells with EC50 of 2.2 nM. Dexamethasone (EC50=36 nM) induces transcription of the β2-receptor is found to correlate with glucocorticoid receptor (GR) DNA binding and occurred at 10-100 fold higher concentrations than the inhibition of GM-CSF release. Dexamethasone (IC50=0.5 nM) inhibits a 3×κB (NF-κB, IκBα, and I-κBβ), which is associated with inhibition of GM-CSF release[2].

In Vivo  

It has previously been reported that treatment with Dexamethasone at a dose of 2×5 mg/kg efficiently inhibits lipopolysaccharide (LPS)-induced inflammation. In our experimental system, treatment with a single dose of Dexamethasone 10 mg/kg (i.p.) significantly decreases recruitment of granulocytes as well as spontaneous production of oxygen radicals compared with animals expose to LPS and injected with solvent alone (saline). The effects are statistically significant when administered both 1 h before and 1 h after inhalation of LPS. The number of granulocytes in BALF decreased to levels comparable to healthy animals (given an aerosol of water)[3].

REFERENCES

[1]. LaLone CA, et al. Effects of a glucocorticoid receptor agonist, Dexamethasone, on fathead minnow reproduction, growth, and development. Environ Toxicol Chem. 2012 Mar;31(3):611-22.

[2]. Adcock IM, et al. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol. 1999 Jun;127(4):1003-11

[3]. Rocksén D, et al. Differential anti-inflammatory and anti-oxidative effects of Dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation. Clin Exp Immunol. 2000 Nov;122(2):249-56